Lynch Syndrome Pathway Navigator - Maidstone, United Kingdom - Maidstone and Tunbridge Wells NHS Trust
Description
Lynch Syndrome is an inherited genetic condition and represents the most common inherited cancer predisposition syndrome accounting for 5% of all colorectal (CRC) and 3% of all endometrial (EC) cancers.
It affects as many as 1 in 270 people in the UK, but only 5% those affected have a diagnosis.
Cancer Alliance Planning Guidance for 2023/24 is to ensure Lynch Syndrome testing is in place for all newly diagnosed colorectal and endometrial cancers and to ensure that all patients who are identified as likely to have Lynch Syndrome are referred for specialised genetic testing in line with NICE guidelines DG27 and DG42.
Secondment may be considered for internal applicants.
Cancer Alliance Planning Guidance for 2023/24 is to ensure Lynch Syndrome testing is in place for all newly diagnosed colorectal and endometrial cancers and to ensure that all patients who are identified as likely to have Lynch Syndrome are referred for specialised genetic testing in line with NICE guidelines DG27 and DG42.
The Molecular Pathology department is part of the West Kent and Medway Cellular Pathology Service and performs MMR testing on Histology specimens.
The post holder will ensure that the eligible patients' samples will progress through the Pathway. It is not a technical scientific post.
Secondment may be considered for internal applicants.
Maidstone and Tunbridge Wells NHS Trust is a large acute hospital Trust in the county of Kent.
The Trust provides a full range of general hospital services and some areas of specialist complex care to around 760,000 people living in the south part of West Kent and the north part of East Sussex.
We work from two main clinical sites:
Maidstone Hospital and Tunbridge Wells Hospital at Pembury.
Tunbridge Wells Hospital opened in 2011 and provides single rooms with en-suites for all in-patients - the first of its kind in the country.
We employ more than 7,000 full and part-time staff in a huge range of clinical and non-clinical roles across both of our hospital sites.
Once your pre-employment checks have been completed you will be contacted by Recruitment to arrange your start date which will be in line with one of our Corporate Inductions.
Interview Date: 22nd February 2024.
The post holder will be the point of contact for the all steps in patient pathways following a diagnosis of either colorectal or endometrial cancer and subsequent referral for MMR testing.
The post holder will co-ordinate with pathology and clinical teams to arrange all necessary testing and to ensure completion of the necessary pathways in conjunction with the Lynch Syndrome Champions for both CRC and EC across sites covered.
The post holder will need to support and facilitate a co-ordinated patient experience focusing on improving the support and tracking of the patient sample through their diagnostics and investigations in a timely manner.
More jobs from Maidstone and Tunbridge Wells NHS Trust
-
Screening Support Administrator
Royal Tunbridge Wells, United Kingdom - 2 weeks ago
-
Senior Data Warehouse Developer
Aylesford, United Kingdom - 5 days ago
-
Endoscopy Booking Clerk
Royal Tunbridge Wells, United Kingdom - 4 days ago
-
Complaints Lead
Maidstone, United Kingdom - 5 days ago
-
Healthcare Support Worker
Maidstone, United Kingdom - 2 weeks ago
-
Macmillan Head and Neck Site Specialist Therapeutic Radiographer
Maidstone, United Kingdom - 3 weeks ago